Davis Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$435 – 1217
2026
Q2
$435 Buy
+5
New +$302 ﹤0.01% 639

Other funds holding CORT

Davis Capital Management's CORT Position: Q3 2026 in Review

Davis Capital Management sold out of Corcept Therapeutics (CORT) in Q3 2026, closing a stake of 5 shares — an estimated $435 sold.

Davis Capital Management first reported a position in CORT in Q2 2026 and held it in 1 quarter. The position peaked at $435 in Q2 2026. 463 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Davis Capital Management reported no remaining Corcept Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Davis Capital Management sold 5 Corcept Therapeutics shares in Q3 2026, an estimated $435.
  • Davis Capital Management first reported a position in Corcept Therapeutics in Q2 2026 and held it in 1 quarter.
  • Davis Capital Management's Corcept Therapeutics position peaked at $435 in Q2 2026.
  • 463 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.